OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Publication Date
Release Date
2025
(4)
2023
(2)
2024
(1)
2022
(1)
2017
(1)
2015
(1)
2014
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Cultivation of
Melilotus officinalis
as a source of bioactive compounds in association with soil recovery practices.
Not available
S-EPMC10523325
|
biostudies-literature
Cite
Risk factors and outcomes of pediatric non-invasive respiratory support failure in Latin America.
Not available
S-EPMC11997567
|
biostudies-literature
Cite
Mitochondria-derived reactive oxygen species induce over-differentiation of neural stem/progenitor cells after non-cytotoxic cisplatin exposure.
Not available
S-EPMC12069383
|
biostudies-literature
Cite
Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells.
Not available
S-EPMC10659074
|
biostudies-literature
Cite
International Consensus Criteria for Pediatric Sepsis and Septic Shock.
Not available
S-EPMC10900966
|
biostudies-literature
Cite
Clinical Outcomes of Hypertonic Saline vs Mannitol Treatment Among Children With Traumatic Brain Injury.
Not available
S-EPMC11897838
|
biostudies-literature
Cite
Evolving epidemiology of HCC in Spain.
Not available
S-EPMC12005282
|
biostudies-literature
Cite
POPULATION GENETICS. Genomic evidence for the Pleistocene and recent population history of Native Americans.
Not available
S-EPMC4733658
|
biostudies-literature
Cite
CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative.
Not available
S-EPMC9305285
|
biostudies-literature
Cite
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Not available
S-EPMC5731244
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets